Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000651947 | SCV000773804 | likely benign | Severe combined immunodeficiency due to IKK2 deficiency | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025844 | SCV004886059 | uncertain significance | Inborn genetic diseases | 2023-02-01 | criteria provided, single submitter | clinical testing | The c.1390T>C (p.C464R) alteration is located in exon 14 (coding exon 13) of the IKBKB gene. This alteration results from a T to C substitution at nucleotide position 1390, causing the cysteine (C) at amino acid position 464 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004692040 | SCV005195908 | uncertain significance | not provided | criteria provided, single submitter | not provided |